The biotech sector is down about 25% year-to-date. The SPDR S&P Biotech ETF (XBI) has been bouncing back and forth. "I like Arcus Biosciences (RCUS) as they have a partnership with Gilead Sciences (GILD). The company has capital to keep it going. Other stock picks include Xencor (XNCR), Merck & Co. (MRK), and Leap Therapeutics (LPTX)," says Mara Goldstein. Next, David Nierengarten weighs in on argenx SE (ARGX) and Blueprint Medicines (BPMC) stocks.
08 Jun 2022
Trading 360
11 Apr 2022
The Watch List
16 Jun 2022
The Watch List
28 Mar 2022
The Watch List
20 May 2022
The Watch List
11 May 2022
The Watch List
28 Mar 2022